- Home
- ATAI vs BBDC Comparison
ATAI vs BBDC Comparison
Compare ATAI & BBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- BBDC
- Stock Information
- Founded
- ATAI 2018
- BBDC 2006
- Country
- ATAI Netherlands
- BBDC United States
- Employees
- ATAI N/A
- BBDC N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- BBDC Diversified Financial Services
- Sector
- ATAI Health Care
- BBDC Finance
- Exchange
- ATAI Nasdaq
- BBDC Nasdaq
- Market Cap
- ATAI 1.1B
- BBDC 971.7M
- IPO Year
- ATAI 2021
- BBDC 2007
- Fundamental
- Price
- ATAI $6.22
- BBDC $8.78
- Analyst Decision
- ATAI Strong Buy
- BBDC Buy
- Analyst Count
- ATAI 5
- BBDC 3
- Target Price
- ATAI $13.40
- BBDC $9.67
- AVG Volume (30 Days)
- ATAI 6.1M
- BBDC 568.7K
- Earning Date
- ATAI 11-12-2025
- BBDC 11-06-2025
- Dividend Yield
- ATAI N/A
- BBDC 12.02%
- EPS Growth
- ATAI N/A
- BBDC N/A
- EPS
- ATAI N/A
- BBDC 0.95
- Revenue
- ATAI $2,309,000.00
- BBDC $280,314,000.00
- Revenue This Year
- ATAI $707.47
- BBDC N/A
- Revenue Next Year
- ATAI N/A
- BBDC N/A
- P/E Ratio
- ATAI N/A
- BBDC $9.12
- Revenue Growth
- ATAI 510.85
- BBDC N/A
- 52 Week Low
- ATAI $1.04
- BBDC $7.66
- 52 Week High
- ATAI $5.97
- BBDC $10.85
- Technical
- Relative Strength Index (RSI)
- ATAI 70.35
- BBDC 45.17
- Support Level
- ATAI $5.06
- BBDC $8.39
- Resistance Level
- ATAI $5.83
- BBDC $8.66
- Average True Range (ATR)
- ATAI 0.38
- BBDC 0.18
- MACD
- ATAI 0.01
- BBDC 0.01
- Stochastic Oscillator
- ATAI 96.75
- BBDC 55.32
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About BBDC Barings BDC Inc.
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.